Executive officer

Elizabeth C. Cushman

Executive Vice President, General Counsel and Secretary·Abbott Laboratories

About

Elizabeth C. Cushman has served as Executive Vice President, General Counsel and Secretary of Abbott since 2025, having been Senior Vice President, Legal from 2024 to 2025 and Vice President, Specialty Legal from 2023 to 2024. She was elected a corporate officer in 2023.

Since 2025
Age 56
Tenure 1 yr

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director

Roles

Organization Role Dates Details
Abbott Laboratories Executive Vice President, General Counsel and Secretary 2025–present Current role
Abbott Laboratories Senior Vice President, Legal 2024 to 2025
Abbott Laboratories Vice President, Specialty Legal 2023 to 2024
Abbott Laboratories Divisional Vice President and Associate General Counsel, Legal Regulatory and Compliance 2021 to 2023
Abbott Laboratories Divisional Vice President and Associate General Counsel, Medical Devices and Established Pharmaceuticals One of numerous legal and compliance positions held since joining Abbott in 2006.

External roles

Organization Role Dates
Clara Abbott Foundation Board of Directors member

Related

Company Abbott Laboratories Company hub Person Nita Ahuja, M.D. Director Person Robert J. Alpern, M.D. Director Person Claire Babineaux-Fontenot Director Person Sally E. Blount, Ph.D. Director Person Robert B. Ford Chairman of the Board and Chief Executive Officer; Director Person Paola Gonzalez Director Person Michelle A. Kumbier Director Person Darren W. McDew Director Person Nancy McKinstry Lead Independent Director Person Michael G. O'Grady Director Person Michael F. Roman Director Person Daniel J. Starks Director Deal Abbott Laboratories Advanced Medical Optics 2009 Deal page Deal Abbott Laboratories Alere 2017 Deal page Deal Abbott Laboratories Basf S Pharmaceutical Business Knoll 2001 Deal page
Source: Abbott Laboratories SEC filings and official company website

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo